[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: Taking Our Academic Medicine
- To: liblicense-l@lists.yale.edu
- Subject: Re: Taking Our Academic Medicine
- From: Matthew Cockerill <matt@biomedcentral.com>0
- Date: Fri, 25 Nov 2005 07:41:43 EST
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
On 23 Nov 2005, at 21:17, David Goodman wrote:
The value of a journal has no connection with its cost to produce, or with its price. The value of a journal is the sum of the scholarly value of its articles to the ultimate users.
David, You've pinpointed what I think is a key issue. If a librarian pays less than "the sum of the scholarly value of its articles to the ultimate users" then the librarian may feel that they are getting a good deal, and in a way they are, for that single transaction looked at in isolation. i.e. "it's great research, it's well worth the money" But take a step back and look at the system, and it's clear that a kind of confidence trick is being pulled here. That research was freely given to the publisher, by the scholarly community. To then justify how much is spent on regaining access to that research in terms of 'the scholarly value of the research' is circular. It amounts to saying: "We need to pay publishers as much as the value of what we gave them (X) [plus any value they've added (Y)] " Why do publishers get paid for X? In a system that functioned effectively as a market, publishers would not be paid according to the total value of the scholarly research (since publishers can't remotely claim to have created all that value). Instead, publishers would be paid according to the value that they add. Paying up front for the service of publication (while making the research itself free) is a very natural way to ensure that what is paid for is the 'value added by the publisher' rather than the 'value of the research itself'. The problem with subscription access to research is that it can be very natural to say - 'it's great research, we must have it at any price.' And so begins the upwards spiral of serials pricing. Matt Cockerill Publisher, BioMed Central
- Prev by Date: Re: Taking Our Academic Medicine
- Next by Date: Professor Sale's study
- Previous by thread: Re: Taking Our Academic Medicine
- Next by thread: Re: Taking Our Academic Medicine
- Index(es):